Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 27100-1 - Provider product page
- Provider
- R&D Systems
- Product name
- Porcine IFN-alpha Antibody
- Antibody type
- Monoclonal
- Description
- Protein A or G purified from hybridoma culture supernatant. Neutralizes pig interferon alpha
- Reactivity
- Porcine
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- K9
- Vial size
- 500 ug
- Storage
- After receipt, this product should be kept at -20°C for retention of full activity. Do not store below -20°C.
Submitted references Cytokine protein expression levels in tracheobronchial lymph node homogenates of pigs infected with pseudorabies virus.
Toll-like receptor 7 and MyD88 knockdown by lentivirus-mediated RNA interference to porcine dendritic cell subsets.
The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response.
Fc gamma RII-dependent sensitisation of natural interferon-producing cells for viral infection and interferon-alpha responses.
Porcine reproductive and respiratory syndrome virus field isolates differ in in vitro interferon phenotypes.
Classical swine fever virus induces proinflammatory cytokines and tissue factor expression and inhibits apoptosis and interferon synthesis during the establishment of long-term infection of porcine vascular endothelial cells.
Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine.
Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine.
Miller LC, Zanella EL, Waters WR, Lager KM
Clinical and vaccine immunology : CVI 2010 May;17(5):728-34
Clinical and vaccine immunology : CVI 2010 May;17(5):728-34
Toll-like receptor 7 and MyD88 knockdown by lentivirus-mediated RNA interference to porcine dendritic cell subsets.
Alves MP, Neuhaus V, Guzylack-Piriou L, Ruggli N, McCullough KC, Summerfield A
Gene therapy 2007 May;14(10):836-44
Gene therapy 2007 May;14(10):836-44
The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response.
de Los Santos T, de Avila Botton S, Weiblen R, Grubman MJ
Journal of virology 2006 Feb;80(4):1906-14
Journal of virology 2006 Feb;80(4):1906-14
Fc gamma RII-dependent sensitisation of natural interferon-producing cells for viral infection and interferon-alpha responses.
Balmelli C, Vincent IE, Rau H, Guzylack-Piriou L, McCullough K, Summerfield A
European journal of immunology 2005 Aug;35(8):2406-15
European journal of immunology 2005 Aug;35(8):2406-15
Porcine reproductive and respiratory syndrome virus field isolates differ in in vitro interferon phenotypes.
Lee SM, Schommer SK, Kleiboeker SB
Veterinary immunology and immunopathology 2004 Dec 8;102(3):217-31
Veterinary immunology and immunopathology 2004 Dec 8;102(3):217-31
Classical swine fever virus induces proinflammatory cytokines and tissue factor expression and inhibits apoptosis and interferon synthesis during the establishment of long-term infection of porcine vascular endothelial cells.
Bensaude E, Turner JL, Wakeley PR, Sweetman DA, Pardieu C, Drew TW, Wileman T, Powell PP
The Journal of general virology 2004 Apr;85(Pt 4):1029-37
The Journal of general virology 2004 Apr;85(Pt 4):1029-37
Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine.
Moraes MP, Chinsangaram J, Brum MC, Grubman MJ
Vaccine 2003 Dec 12;22(2):268-79
Vaccine 2003 Dec 12;22(2):268-79
Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine.
Moraes MP, Chinsangaram J, Brum MC, Grubman MJ
Vaccine 2003 Dec 12;22(2):268-79
Vaccine 2003 Dec 12;22(2):268-79
No comments: Submit comment
No validations: Submit validation data